These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10714558)

  • 1. Interleukin-18 in combination with IL-2 enhances natural killer cell activity without inducing large amounts of IFN-gamma in vivo.
    Arai N; Akamatsu S; Arai S; Toshimori Y; Hanaya T; Tanimoto T; Ikeda M; Tomura M; Fujiwara H; Kurimoto M
    J Interferon Cytokine Res; 2000 Feb; 20(2):217-24. PubMed ID: 10714558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth.
    Chaudhry UI; Kingham TP; Plitas G; Katz SC; Raab JR; DeMatteo RP
    Cancer Res; 2006 Nov; 66(21):10497-504. PubMed ID: 17079471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo.
    Gately MK; Warrier RR; Honasoge S; Carvajal DM; Faherty DA; Connaughton SE; Anderson TD; Sarmiento U; Hubbard BR; Murphy M
    Int Immunol; 1994 Jan; 6(1):157-67. PubMed ID: 7908534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver.
    Subleski JJ; Hall VL; Back TC; Ortaldo JR; Wiltrout RH
    Cancer Res; 2006 Nov; 66(22):11005-12. PubMed ID: 17108139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
    Lauwerys BR; Renauld JC; Houssiau FA
    Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between TLR3 and IL-18 promotes IFN-γ dependent TRAIL expression in human liver NK cells.
    Tu Z; Hamalainen-Laanaya HK; Crispe IN; Orloff MS
    Cell Immunol; 2011; 271(2):286-91. PubMed ID: 21802664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 18 induces a synergistic enhancement of interferon gamma production in mixed murine spleen cell-tumor cell cultures: role of endogenous interleukin 12.
    Micallef MJ; Tanimoto T; Kohno K; Ikegami H; Kurimoto M
    Cancer Detect Prev; 2000; 24(3):234-43. PubMed ID: 10975285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.
    Hunter CA; Timans J; Pisacane P; Menon S; Cai G; Walker W; Aste-Amezaga M; Chizzonite R; Bazan JF; Kastelein RA
    Eur J Immunol; 1997 Nov; 27(11):2787-92. PubMed ID: 9394800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity.
    Micallef MJ; Tanimoto T; Torigoe K; Nishida Y; Kohno K; Ikegami H; Kurimoto M
    Cancer Immunol Immunother; 1999; 48(2-3):109-17. PubMed ID: 10414464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-gamma and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2.
    Wigginton JM; Lee JK; Wiltrout TA; Alvord WG; Hixon JA; Subleski J; Back TC; Wiltrout RH
    J Immunol; 2002 Oct; 169(8):4467-74. PubMed ID: 12370382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
    Salagianni M; Lekka E; Moustaki A; Iliopoulou EG; Baxevanis CN; Papamichail M; Perez SA
    J Immunol; 2011 Mar; 186(6):3327-35. PubMed ID: 21317394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production.
    Micallef MJ; Ohtsuki T; Kohno K; Tanabe F; Ushio S; Namba M; Tanimoto T; Torigoe K; Fujii M; Ikeda M; Fukuda S; Kurimoto M
    Eur J Immunol; 1996 Jul; 26(7):1647-51. PubMed ID: 8766574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.
    Redlinger RE; Mailliard RB; Lotze MT; Barksdale EM
    J Pediatr Surg; 2003 Mar; 38(3):301-7; discussion 301-7. PubMed ID: 12632339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance.
    Sherwood ER; Varma TK; Fram RY; Lin CY; Koutrouvelis AP; Toliver-Kinsky TE
    Clin Sci (Lond); 2001 Dec; 101(6):541-50. PubMed ID: 11724637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.